Co-Diagnostics, Inc.
CODX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001692415
No open-market purchases or sales by Co-Diagnostics, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $1.85M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Co-Diagnostics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 88 | 2 | 78 | −8 |
| Shares | 7.25M | 143.2K | 7.99M | +884.2K (+12.4%) |
| Value | $59.8M | $1.18M | $77.6M | +$19.0M (+32.4%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Co-Diagnostics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Easterly Investment Partners LLC | 162,190 | $1.58M | 0.11% |
| SummerHaven Investment Management, LLC | 109,515 | $1.07M | 0.62% |
| Prairiewood Capital, LLC | 59,357 | $578.0K | 0.47% |
| First Trust Advisors LP | 38,596 | $376.0K | 0.00% |
| PDT Partners, LLC | 20,671 | $201.0K | 0.01% |
| Janney Montgomery Scott LLC | 20,320 | $198.0K | 0.00% |
| State of Tennessee, Treasury Department | 19,412 | $189.0K | 0.00% |
| LifePro Asset Management | 19,151 | $186.0K | 0.06% |
| Raymond James Financial Services Advisors, Inc. | 11,963 | $116.0K | 0.00% |
| Black Swift Group, LLC | 10,000 | $97.0K | 0.04% |
| Walleye Trading LLC | 8,439 | $82.0K | 0.00% |
| Lazard Asset Management LLC | 8,083 | $78.0K | 0.00% |
| NEXT Financial Group, Inc | 3,150 | $31.0K | 0.00% |
| Deutsche Bank AG | 110 | $1.00K | 0.00% |
Sold out (22)
Institutions that held Co-Diagnostics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Ergoteles LLC | 136,600 | $1.13M |
| AQR Capital Management LLC | 85,784 | $708.0K |
| Harvest Investment Services, LLC | 69,548 | $573.0K |
| ExodusPoint Capital Management, LP | 64,727 | $534.0K |
| Jane Street Group, LLC | 60,195 | $497.0K |
| D. E. Shaw & Co., Inc. | 36,243 | $299.0K |
| Qube Research & Technologies Ltd | 34,308 | $283.0K |
| Tibra Equities Europe Ltd | 34,100 | $281.0K |
| Squarepoint Ops LLC | 22,181 | $183.0K |
| Cannon Global Investment Management, LLC | 16,400 | $135.0K |
| IFG Advisory, LLC | 15,626 | $128.0K |
| Natixis | 14,000 | $116.0K |
| LMR Partners LLP | 13,857 | $114.0K |
| Boothbay Fund Management, LLC | 11,582 | $96.0K |
| Verition Fund Management LLC | 10,000 | $83.0K |
| Credit Agricole S A | 7,000 | $58.0K |
| Paragon Wealth Strategies, LLC | 1,000 | $8.00K |
| Geneos Wealth Management Inc. | 400 | $3.00K |
| New York State Common Retirement Fund | 219 | $2.00K |
| Citigroup Inc | 75 | $1.00K |
| Retirement Group, LLC | 35 | $0 |
| Financial Advocates Investment Management | 9,407 | – |
Not filed for Q3 2021 yet (2)
Institutions that held Co-Diagnostics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Snow Capital Management LP | 142,681 | $1.18M |
| CWM, LLC | 500 | $4.00K |